[Physiopathology of COPD: choosing the right therapeutic targets].
Devillier
P
P
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000368:Aged; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D001424:Bacterial Infections / Q000150:complications; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002264:Carboxylic Acids; D003509:Cyclohexanecarboxylic Acids; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D009079:Mucociliary Clearance; D009570:Nitriles; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011650:Pulmonary Alveoli / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000503:physiopathology*; D011656:Pulmonary Emphysema / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D020889:Rolipram / Q000008:administration & dosage / Q000627:therapeutic use; D000068299:Salmeterol Xinafoate; D012907:Smoking / Q000009:adverse effects / Q000503:physiopathology; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D002264:Carboxylic Acids; D003509:Cyclohexanecarboxylic Acids; D009570:Nitriles; D010726:Phosphodiesterase Inhibitors; D000068299:Salmeterol Xinafoate; C433247:Cilomilast; D013806:Theophylline; D020889:Rolipram; D000420:Albuterol
Physiopathologie de la BPCO: quelles cibles thérapeutiques?